Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola

The 2014-2016 Ebola outbreak in West Africa was the largest in history leading to 28,639 cases, of which 40% were fatal. Better treatments and effective vaccines against Ebola virus are needed to prevent future recurrence. Multiple, novel, treatment options were assessed during the outbreak, includi...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Tan, T, Rijal, P, Townsend, A, Hyde, S, Gill, D
פורמט: Conference item
יצא לאור: Elsevier 2017